A South Korean based Pharmaceutical company required audit to be conducted for their study facility, clinical study data, bioanalytical data, and Integrated Study Report (ISR) to evaluate the suitability of the study data for Europe submission and applicable GCP standards. No existing data and quick notice to respond were the initial bottlenecks Freyr had to deal with.

Read this case to decode how Freyr helped the client for total audit process in 2 weeks and with 40% cost savings.